Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zometa in combination with chemotherapy for stage IIIB/IV non-small cell lung cancer
NCT00086268Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Oct 2007
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in non-small cell lung carcinoma (NSCLC), sponsored by Novartis. Started Apr 2004; status: completed.
02
Drugs
zoledronic acid
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT00086268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086268.